|
SGMO Sangamo Therapeutics Inc 1001233 |
| Balance Sheet |
|
Current Assets
|
58,131,000 |
|
Assets
|
111,263,000 |
|
Current Liabilities
|
43,161,000 |
|
Liabilities
|
72,129,000 |
|
Equity
|
39,134,000 |
|
Shares Out
|
208,221,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-63,788,000 |
|
Investing Cash Flow
|
36,200,000 |
| Market Analysis |
Market Cap
|
176,820,653 |
|
Price
|
0.87 |
|
BVPS
|
0.19 |
|
PB
|
4.63 |
|
EPS
|
-1.38 |
|
PS
|
0.89 |
|
FCF
|
-27,588,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/31 |
|
11/12 |
0.05 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SGMO documents filed with the SEC.
SGMO Filings
Clear
